about
Serotonylation of vascular proteins important to contractionPlasma serotonin levels and the platelet serotonin transporterEnhancement of mesenteric artery contraction to 5-HT depends on Rho kinase and Src kinase pathways in the ob/ob mouse model of type 2 diabetes5-hydroxtryptamine receptors in systemic hypertension: an arterial focus.Molecular mechanisms of SERT in platelets: regulation of plasma serotonin levels.The cardiac ventricular 5-HT4 receptor is functional in late foetal development and is reactivated in heart failure.Comparison of the function of the serotonin transporter in the vasculature of male and female rats.Serotonin and blood pressure regulation.Antenatal dexamethasone treatment leads to changes in gene expression in a murine late placenta.Oxaliplatin-induced severe anaphylactic reactions in metastatic colorectal cancer: case series analysis.5-hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT).A serotonergic system in veins: serotonin transporter-independent uptake.Vasoactive peptides in cardiovascular (patho)physiology.Lack of the serotonin transporter does not prevent mineralocorticoid hypertension in rat and mouse.Modeling serotonin uptake in the lung shows endothelial transporters dominate over cleft permeationDepression and chronic diseases: it is time for a synergistic mental health and primary care approach.Anaphylactic reactions presenting with hypertension.Serotonin uptake rates in platelets from angiotensin II-induced hypertensive mice.Facilitation of serotonin-induced contraction of rat mesenteric artery by ketamineSerotonin contracts the rat mesenteric artery by inhibiting 4-aminopyridine-sensitive Kv channels via the 5-HT2A receptor and Src tyrosine kinase.Molecular interactions of serotonin (5-HT) and endothelin-1 in vascular smooth muscle cells: in vitro and ex vivo analyses.Nortriptyline, a tricyclic antidepressant, inhibits voltage-dependent K+ channels in coronary arterial smooth muscle cells.Oh, the places you'll go! My many colored serotonin (apologies to Dr. Seuss).Src tyrosine kinases contribute to serotonin-mediated contraction by regulating calcium-dependent pathways in rat skeletal muscle arteries.The existence of a local 5-hydroxytryptaminergic system in peripheral arteries.One-month serotonin infusion results in a prolonged fall in blood pressure in the deoxycorticosterone acetate (DOCA) salt hypertensive rat.Mechanisms of U46619- and 5-HT-induced contraction of bovine pulmonary arteries: role of chloride ions.The beginning of a fantastic, unanswered question: is 5-HT involved in systemic hypertension?The love of a lifetime: 5-HT in the cardiovascular system.c-Src tyrosine kinase, a critical component for 5-HT2A receptor-mediated contraction in rat aorta.Neonatal SSRI exposure improves mitochondrial function and antioxidant defense in rat heart.Vascular reactivity, 5-HT uptake, and blood pressure in the serotonin transporter knockout rat.N-nitroso-melatonin releases nitric oxide in the presence of serotonin and its derivatives.Elevated Serotonin Interacts with Angiotensin-II to Result in Altered Valve Interstitial Cell Contractility and Remodeling.Selective serotonin reuptake inhibitor sertraline inhibits voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells.Is serotonin a valuable parameter in peripheral arterial disease?A new signaling paradigm for serotonin: use of Crk-associated substrate in arterial contraction.Endothelin-1, nitric oxide, serotonin and high blood pressure in male adolescents
P2860
Q21562428-B734CCAA-E399-493F-950F-9E8072F80498Q24306106-0794A630-E10A-4105-BD41-623E0C2683C2Q28749389-90DB9FFC-4F77-4ECC-9BD0-709702609E0AQ34145991-2FF1BFB9-3704-41E9-9060-76097E6A1DA1Q34248836-2F547939-398D-44DD-A713-3FA089454706Q34429191-1A6E251D-0B5E-42C7-91FE-80918C81AFCFQ34917758-50349271-393A-486C-9630-D618F392B3ABQ35847080-AEB91DB9-A826-4927-9280-615366AE103DQ36088980-348A5A5C-7235-41CB-AC9D-C0CC41C71E07Q36316717-3585F12D-E55A-4E97-8DD9-BB1C1C1FF6D8Q36514263-C6148244-BD13-4853-A885-474B0DC3F624Q36767166-1E7D34B4-4CC6-4B86-AA55-C80E5807477AQ36815987-2D397815-C235-44D5-AF5C-0E8DB474FB3AQ36857584-B2CDECC9-3670-4ADC-B7CD-9AC6058FB343Q37054478-D899EF12-DF26-4A71-B617-184E34DCDD51Q37070407-7A8AD534-AF19-425D-A21E-B8AFF7205CD2Q37146819-E29BE89B-0EDD-4885-A451-690F9F474ED3Q37250033-8F745685-0814-47B0-9EEC-A57B28F602DCQ37409969-37D18406-7E68-408C-AC57-7A27F7A77922Q37432060-02E2094A-7431-4075-8AE9-9717C4235637Q37575289-9B628DAA-6D79-4ECB-9DDB-987EC97EFBA9Q37689520-06AADB47-8242-402C-A7D5-B1798A7C7604Q38963210-660EE3C0-66AB-49BE-9071-8435CA60B332Q38965336-4AF01A66-044A-4E4F-9BD0-56994BDAA5E2Q39560973-3AD51E20-54EC-4DD1-ACEC-0A8CC669B1C3Q41814079-C00AD97A-627A-447D-A616-89CE93EEFF6BQ42137690-46DA8F7D-4249-4C49-8036-1D4771DC8D42Q46384819-76AE074B-9BCA-4AA2-864E-3FBB5456397CQ46407178-B4926F94-596D-4B15-9505-B624803DBC98Q46503286-E8B8D0F1-8A9E-4B9F-B1BB-C2D6DEA07C86Q46585880-8CC0C39A-B4E8-4EF2-AB86-EE9CBB5D4D68Q46761908-922CA027-F6DE-436E-B738-E19E7132619AQ46971004-BA63FC2B-DA9B-4231-B4DC-7349E3F0D0E8Q50214900-4339042E-1D9E-47F2-B456-BA9A7AAC117AQ51267562-7ED6B652-BC73-4459-BF61-146ACBB514B7Q51317498-D885E31B-ADC7-4F06-91AF-795A17C41C6FQ52572352-FD1E52E0-4EAF-4475-B8B1-631FA8969CADQ57074155-3A8DD894-AECB-4C4D-B337-8D1D0F9D06AF
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
5-HT in systemic hypertension: foe, friend or fantasy?
@ast
5-HT in systemic hypertension: foe, friend or fantasy?
@en
type
label
5-HT in systemic hypertension: foe, friend or fantasy?
@ast
5-HT in systemic hypertension: foe, friend or fantasy?
@en
prefLabel
5-HT in systemic hypertension: foe, friend or fantasy?
@ast
5-HT in systemic hypertension: foe, friend or fantasy?
@en
P356
P1433
P1476
5-HT in systemic hypertension: foe, friend or fantasy?
@en
P2093
Stephanie W Watts
P304
P356
10.1042/CS20040364
P407
P577
2005-05-01T00:00:00Z